Veritas Collagen Matrix, from Synovis Life Technologies, is an innovative
non-cross-linked biologic material derived from bovine pericardium
indicated for use as an implant for the surgical repair of soft tissue
deficiencies, including abdominal wall and thoracic wall
repair, muscle flap reinforcement, and repair of hernias . Veritas is
produced through a patented process that results in an extremely
biocompatible and highly acellular remodelable material. Once implanted,
Veritas provides a scaffold for connective tissue protein synthesis and
host tissue in-growth. The result is the seamless integration of Veritas
into the surrounding host tissue.
Veritas has been used successfully in contaminated wounds and in the
presence of infection as well as in other challenging situations. The U.S.
Food and Drug Administration (FDA) granted Synovis the following additional
indication: Veritas minimizes tissue attachment to the material when in
direct contact with viscera. Veritas is the first biologic to have received
this important indication from the FDA.
Veritas has been used successfully in a variety of surgical procedures
including: complex abdominal wall repair, laparoscopic hiatal hernia
repair, chest wall reconstruction, and breast reconstruction.
Veritas Collagen Matrix, from Synovis Life Technologies, is an innovative
non-cross-linked biologic material derived from bovine pericardium
indicated for use as an implant for the surgical repair of soft tissue
deficiencies, including abdominal wall and thoracic wall
repair, muscle flap reinforcement, and repair of hernias . Veritas is
produced through a patented process that results in an extremely
biocompatible and highly acellular remodelable material. Once implanted,
Veritas provides a scaffold for connective tissue protein synthesis and
host tissue in-growth. The result is the seamless integration of Veritas
into the surrounding host tissue.
Veritas has been used successfully in contaminated wounds and in the
presence of infection as well as in other challenging situations. The U.S.
Food and Drug Administration (FDA) granted Synovis the following additional
indication: Veritas minimizes tissue attachment to the material when in
direct contact with viscera. Veritas is the first biologic to have received
this important indication from the FDA.
Veritas has been used successfully in a variety of surgical procedures
including: complex abdominal wall repair, laparoscopic hiatal hernia
repair, chest wall reconstruction, and breast reconstruction.
This conference is designed for the experienced surgeon who is familiar
with standard aesthetic procedures and wishes to learn more about newer,
better technologies and techniques to enhance his or her practice. Tulip
BioMed is demonstrating its disposable, minimally-invasive micro-cannulas
for fat harvest, transfer and re-injection that are already on the market
plus a series of five, versatile, disposable cannula models that will work
with standard aspiration machines as well as the syringe system (aesthetic)
method of liposuction.
This conference follows closely after the successful showing for Tulip
BioMed at the “Plastic Surgery 2006″ tradeshow in San Francisco from Oct
6-11, where the new instruments were well-received by physicians who are
concerned about patient safety and results. J. William Little, MD, a
well-known, Washington, DC-based aesthetic plastic surgeon who is a key
specialist in fat transfer techniques, believes the Tulip BioMed
instruments will help to advance the industry further in the areas of
living tissue management where fat may be transferred from one part of the
body to another in aesthetic procedures.
“Plastic surgerys recent emphasis on the reversal of mid-facial descent,
combined with replacement — rather than removal — of lower eyelid fat,
has made a difference in the quality of results,” says Dr. Little. “Good
surgeons are always looking for better and safer instrumentation. Tulips
blunt tip disposable cannulas will help us perform safer surgeries with
more predictable results and are convenient for the O.R. staff.”
New York carboxy therapy
No comments »